Unconjugated hyperbilirubinemia during treatment with chenodeoxycholic acid

Gastroenterology. 1979 Jul;77(1):121-2.

Abstract

The authors describe a slight but significant increase in the serum levels of indirect-reacting bilirubin in gallstone patients after 3 and 6 mo of treatment with chenodeoxycholic acid. A return to pretreatment values was noted at 9 mo. The mechanism of this abnormality remains unclear. Two explanations are theoretically possible: a subclinical hemolysis or a modification of the hepatic transport and/or the conjugation of bilirubin.

MeSH terms

  • Chenodeoxycholic Acid / adverse effects*
  • Chenodeoxycholic Acid / therapeutic use
  • Cholelithiasis / drug therapy*
  • Female
  • Humans
  • Hyperbilirubinemia / chemically induced*
  • Male
  • Time Factors

Substances

  • Chenodeoxycholic Acid